ConductScience.org, home

Paper32109369

Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.

Favuzza P and 31 others. Cell Host Microbe, 2020. Cited by 108 papers, by iCite.

Cite this record

ConductScience Library. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle. Papers, record 32109369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32109369

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
PubMed
Journal
Cell Host Microbe
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
108
iCite
Relative citation ratio, by iCite
5.86
iCite
Revised in PubMed
2024-04-25
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Favuzza PPaola
2de Lera Ruiz MManuel
3Thompson JKJennifer K
4Triglia TTony
5Ngo AAnna
6Steel RWJRyan W J
7Vavrek MMarissa
8Christensen JJanni
9Healer JJulie
10Boyce CChristopher
11Guo ZZhuyan
12Hu MMengwei
13Khan TTanweer
14Murgolo NNicholas
15Zhao LLianyun
16Penington JSJocelyn Sietsma
17Reaksudsan KKitsanapong
18Jarman KKate
19Dietrich MHMelanie H
20Richardson LLachlan

Source PubMed

See all 32 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
Aspartic Acid EndopeptidasesMajor topic
MalariaMajor topic
Animals
Disease Transmission, Infectious
Life Cycle Stages
Merozoites
Mice
Mice, Transgenic
Plasmodium berghei
Plasmodium falciparum

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32272073Targeting Plasmepsins-An Achilles' Heel of the Malaria Parasite.https://conductscience.org/library/papers/32272073

Source PubMed

Download CSV of comments and corrections

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117220424Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17220424PubMed
226566155The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies.Annu Rev Pharmacol Toxicol2016https://conductscience.org/library/papers/26566155PubMed
311707616Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.Protein Eng2001https://conductscience.org/library/papers/11707616PubMed
425236618DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.Genome Res2014https://conductscience.org/library/papers/25236618PubMed
529074775A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.Science2017https://conductscience.org/library/papers/29074775PubMed
621813454SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data.Nucleic Acids Res2011https://conductscience.org/library/papers/21813454PubMed
718591232Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5.Infect Immun2008https://conductscience.org/library/papers/18591232PubMed
819596869Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19596869PubMed
917040128Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria.PLoS Pathog2006https://conductscience.org/library/papers/17040128PubMed
1026214367Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.Nat Struct Mol Biol2015https://conductscience.org/library/papers/26214367PubMed
1131229233Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study.Lancet2019https://conductscience.org/library/papers/31229233PubMed
1221909271Hostile takeover by Plasmodium: reorganization of parasite and host cell membranes during liver stage egress.PLoS Pathog2011https://conductscience.org/library/papers/21909271PubMed
1323049965Subcompartmentalisation of proteins in the rhoptries correlates with ordered events of erythrocyte invasion by the blood stage malaria parasite.PLoS One2012https://conductscience.org/library/papers/23049965PubMed
1415051281A large focus of naturally acquired Plasmodium knowlesi infections in human beings.Lancet2004https://conductscience.org/library/papers/15051281PubMed
1520855594Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20855594PubMed
1621778402Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide.Science2011https://conductscience.org/library/papers/21778402PubMed
1726888201Alternative methods for the Plasmodium falciparum artemisinin ring-stage survival assay with increased simplicity and parasite stage-specificity.Malar J2016https://conductscience.org/library/papers/26888201PubMed
1828186186P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5.Nat Commun2017https://conductscience.org/library/papers/28186186PubMed
1928289248Antimalarial Drug Resistance: A Threat to Malaria Elimination.Cold Spring Harb Perspect Med2017https://conductscience.org/library/papers/28289248PubMed
2019614665Reticulocyte binding protein homologues are key adhesins during erythrocyte invasion by Plasmodium falciparum.Cell Microbiol2009https://conductscience.org/library/papers/19614665PubMed

See all 79 referencesDownload CSV of references

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.

PMIDTitleJournalYearIn PapersSource
42864316Dynamic hinge-motion of PfRIPR revealed by malaria invasion inhibitory antibodies.Nat Commun2026https://conductscience.org/library/papers/42864316PubMed
42709875Dual plasmepsin IX and X inhibitors are refractory to development of resistance.PLoS Pathog2026https://conductscience.org/library/papers/42709875PubMed
42587390Deconstruction of Aspartic Protease Inhibitors Enables Fragment-Based Discovery of Plasmepsin V Inhibitors.ChemMedChem2026https://conductscience.org/library/papers/42587390PubMed
42363834In vitro and in vivo activity of the aspartic protease inhibitor CWHM-117 against Toxoplasma gondii.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42363834PubMed
42227058Plasmepsins as Antimalarial Drug Targets-Then, Now, and the Future.Med Res Rev2026https://conductscience.org/library/papers/42227058PubMed
42126260Conformational Dynamics of Plasmepsin X during Inhibitor Binding.J Phys Chem B2026https://conductscience.org/library/papers/42126260PubMed
42113900Spatiotemporal dynamics of signal dependent exocytosis and parasitophorous vacuolar membrane rupture during Plasmodium falciparum egress.PLoS Pathog2026https://conductscience.org/library/papers/42113900PubMed
41593365Babesia divergens host cell egress is mediated by essential and druggable kinases and proteases.Nat Microbiol2026https://conductscience.org/library/papers/41593365PubMed
41532789First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studies.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41532789PubMed
41329554Deconvolution of the On-Target Activity of Plasmepsin V Peptidomimetics in Plasmodium falciparum Parasites.ACS Infect Dis2025https://conductscience.org/library/papers/41329554PubMed
41035680An overview of the interconnectedness of the PEXEL and non-PEXEL mediated protein export in Plasmodium falciparum.iScience2025https://conductscience.org/library/papers/41035680PubMed
40901734Cryptosporidium aspartyl protease 2 is required for host cell egress of merozoites and male gametes.Mol Biol Cell2025https://conductscience.org/library/papers/40901734PubMed
40841669Aspartyl protease inhibition interferes with Plasmodium falciparum asexual blood-stage and early gametocyte development.Malar J2025https://conductscience.org/library/papers/40841669PubMed
40680058Optimization and Characterization of the Antimalarial Activity of N-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1.J Med Chem2025https://conductscience.org/library/papers/40680058PubMed
40592953Functional characterisation of components in two Plasmodium falciparum Cullin-RING-Ligase complexes.Sci Rep2025https://conductscience.org/library/papers/40592953PubMed
40551195Technologies for the point-of-care diagnosis of malaria: a scoping review.Infect Dis Poverty2025https://conductscience.org/library/papers/40551195PubMed
40257030Innovations in Antimalarial Drug Discovery: New Targets and Leads.Curr Drug Targets2025https://conductscience.org/library/papers/40257030PubMed
40035447Structure-activity analysis of imino-pyrimidinone-fused pyrrolidines aids the development of dual plasmepsin V and plasmepsin X inhibitors.FEBS J2025https://conductscience.org/library/papers/40035447PubMed
39920505Malaria parasite cysteine and aspartic proteases as key drug targets for antimalarial therapy.J Mol Model2025https://conductscience.org/library/papers/39920505PubMed
39642214Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission.Sci Adv2024https://conductscience.org/library/papers/39642214PubMed

See all 77 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32109369

GET https://conductscience.org/api/papers/v1/32109369/authors?page=2